Comparative effectiveness of 8 versus 12 weeks of Ombitasvir/Paritaprevir/ritonavir and Dasabuvir in treatment-naïve patients infected with HCV genotype 1b with non-advanced hepatic fibrosis.
暂无分享，去创建一个
M. Pawłowska | E. Janczewska | R. Flisiak | W. Halota | J. Jaroszewicz | W. Mazur | A. Garlicki | K. Tomasiewicz | A. Piekarska | B. Lorenc | J. Klapaczyński | M. Tudrujek-Zdunek | M. Sitko | D. Zarębska-Michaluk | I. Buczyńska | D. Dybowska | A. Czauż-Andrzejuk | R. Krygier | J. Citko | B. Dobracka | Z. Deroń | Ł. Laurans | O. Tronina | P. Pabjan | T. Belica-Wdowik | B. Baka-Ćwierz | J. Białkowska | K. Simon